| Katie Elaine White, AUD | |
|
1801 1st Ave Ste 3a, Longview, WA 98632-3271 | |
| (360) 636-4469 | |
| Not Available |
| Full Name | Katie Elaine White |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 7 Years |
| Location | 1801 1st Ave Ste 3a, Longview, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134612823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 3672 (Idaho) | Secondary |
| 231H00000X | Audiologist | LD60965806 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 5890689293 | 182 |
| Peacehealth | 8820178288 | 169 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
The University of Edinburgh has received nearly £5 million to tackle the coronavirus pandemic from the government's rapid response call.
Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 3 days ago
| Provider Name | Peacehealth |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
The University of Edinburgh has received nearly £5 million to tackle the coronavirus pandemic from the government's rapid response call.
Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 3 days ago
| Provider Name | Peacehealth |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609061969 PECOS PAC ID: 8820178288 Enrollment ID: O20080110000429 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
The University of Edinburgh has received nearly £5 million to tackle the coronavirus pandemic from the government's rapid response call.
Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie Elaine White, AUD 1801 1st Ave Ste 3a, Longview, WA 98632-3271 Ph: (360) 636-4469 | Katie Elaine White, AUD 1801 1st Ave Ste 3a, Longview, WA 98632-3271 Ph: (360) 636-4469 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
The University of Edinburgh has received nearly £5 million to tackle the coronavirus pandemic from the government's rapid response call.
Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
› Verified 3 days ago
All American Hearing Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2025 9th Avenue, Suite 100, Longview, WA 98632 Phone: 360-425-8242 | |
Luke Weston Hinson, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1801 1st Ave Ste 3a, Longview, WA 98632 Phone: 606-364-4693 Fax: 360-425-4970 | |
Sheri Resendez, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 843 12th Ave, Ste A, Longview, WA 98632 Phone: 360-577-7702 Fax: 360-636-5447 | |
Susan K Healea, MA-CCCA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 820 11th Ave, Longview, WA 98632 Phone: 360-423-0960 Fax: 360-423-8778 |